Datta Sunando, Antonyak Marc A, Cerione Richard A
Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, USA.
Biochemistry. 2006 Nov 7;45(44):13163-74. doi: 10.1021/bi0606795.
Tissue transglutaminase II (TGase-II), which is capable of both GTP binding and transamidation activities, has been implicated in a variety of biological disorders ranging from cancer to neurodegenerative diseases. Recent studies have suggested that the transamidation activity of TGase-II is necessary for the survival of cancer cells confronted with different stresses and cellular insults. When assayed in vitro, the transamidation activity of TGase-II is Ca(2+)-dependent. However, at present, little is known with regard to how the regulation by Ca(2+) is manifested or if in fact it is important for the cellular functions of TGase-II. Here, we have set out to further examine the Ca(2+)-mediated regulation of TGase-II's transamidation activity, with our goals being to identify the Ca(2+)-regulatory sites on the protein and determine whether they are essential for TGase-II to confer survival to human breast cancer cells. On the basis of comparisons between the X-ray crystal structures of TGase-II and TGase-III, we identified three putative Ca(2+)-regulatory sites on TGase-II. Site-directed mutagenesis was performed to individually alter key residues at each of the sites. These substitutions did not affect the ability of TGase-II to bind guanine nucleotides, nor did they cause any obvious changes in its cellular localization. While substitutions at the different Ca(2+)-regulatory sites could either slightly enhance or markedly reduce the GTP hydrolytic activity of TGase-II, mutations at each of the three sites inhibited the Ca(2+)-responsive transamidation activity. We further showed that the same substitutions inhibited the ability of TGase-II to protect human breast cancer cells against the apoptotic activity of doxorubicin. Overall, these findings demonstrate that the Ca(2+)-mediated regulation of transamidation activity is essential for the ability of TGase-II to confer cell survival.
组织转谷氨酰胺酶II(TGase-II)具有GTP结合活性和转酰胺基活性,与从癌症到神经退行性疾病等多种生物学紊乱有关。最近的研究表明,TGase-II的转酰胺基活性对于面临不同应激和细胞损伤的癌细胞存活是必需的。在体外测定时,TGase-II的转酰胺基活性是Ca(2+)依赖性的。然而,目前对于Ca(2+)的调节如何表现,或者它实际上对TGase-II的细胞功能是否重要知之甚少。在这里,我们着手进一步研究Ca(2+)介导的对TGase-II转酰胺基活性的调节,目标是确定该蛋白上的Ca(2+)调节位点,并确定它们对于TGase-II赋予人乳腺癌细胞存活能力是否至关重要。基于TGase-II和TGase-III的X射线晶体结构比较,我们在TGase-II上确定了三个假定的Ca(2+)调节位点。进行了定点诱变以分别改变每个位点的关键残基。这些取代不影响TGase-II结合鸟嘌呤核苷酸的能力,也未引起其细胞定位的任何明显变化。虽然在不同Ca(2+)调节位点的取代可轻微增强或显著降低TGase-II的GTP水解活性,但三个位点中的每个位点的突变均抑制了Ca(2+)反应性转酰胺基活性。我们进一步表明,相同的取代抑制了TGase-II保护人乳腺癌细胞免受阿霉素凋亡活性影响的能力。总体而言,这些发现表明Ca(2+)介导的对转酰胺基活性的调节对于TGase-II赋予细胞存活的能力至关重要。